Eu Leong Yong

Yong Eu Leong

  • Professor, Department of Obstetrics & Gynaecology
  • Senior Consultant, Department of Obstetrics & Gynaecology, National University Health System
Administrative Appointment(s)
  • Head, Department of Obstetrics & Gynaecology, NUS Yong Loo Lin School of Medicine
Academic Qualifications
  • PhD, National University of Singapore, Singapore
  • MBBS, National University of Singapore, Singapore
  • MRCOG, Royal College of Obstetrics & Gynaecology, United Kingdom
Research Interest(s)
  • Integrated Women's Health Programme
  • Botanical Drug Development
  • Polycystic Ovarian Syndrome
  • Osteoporosis
  • Ageing
  • Drug Development
  • Steroid/Nuclear Receptor Biology
  • Human Diseases
Recent Publications
  • 1. Lim RZL, Li L, Chew N, Yong EL. 2017 Dec. The prenylflavonoid Icaritin enhances osteoblast proliferation and function by signal transducer and activator of transcription factor 3 (STAT-3) regulation of C-X-C chemokine receptor type 4 (CXCR4) expression. Bone. 105:122-133. doi: 10.1016/j.bone.2017.08.028.
  • 2. Lin HZ, Tambyah PA, Yong EL, Biswas A, Chan SY. 2017 Apr. A review of Zika virus infections in pregnancy and implications for antenatal care in Singapore. Singapore Medical Journal. 58(4):171-178. doi:10.11622/smedj.2017026.
  • 3. Tan EM, Li L, Indran IR, Chew N, Yong EL. 2017 Apr. TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid. Journal of Bone and Mineral Research. 32(4):846-860. doi:10.1002/jbmr.3031.
  • 4. Sun F, Zhang ZW, Tan EM, Lim ZLR, Li Y, Wang XC, Chua SE, Li J, Cheung E, Yong EL. 2016 Jul. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice. Carcinogenesis. 37(7):701-711. doi:10.1093/carcin/bgw044.
  • 5. Indran IR, Liang RLZ, Min TE, Yong EL. 2016 Jun. Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health. Pharmacology and Therapeutics. 162:188-205. doi: 10.1016/j.pharmthera.2016.01.015.